Passionate about driving transformative global health initiatives in pharmaceutical research, I excel in managing complex programs that leverage big data and AI to advance medical innovation. With a proven track record in collaborative research, I specialize in bridging academia, industry, and public health sectors. My expertise includes strategic partnership development with pharmaceutical companies, research institutions, and government agencies, ensuring successful execution of high-impact projects. Proficient in navigating regulatory landscapes, I craft and implement data-driven strategies to tackle healthcare challenges, utilizing advanced analytics and machine learning. As a seasoned leader, I foster a culture of innovation within interdisciplinary teams, guiding both junior researchers and experienced professionals to drive meaningful change in global healthcare.
Partnership Management
Program Leadership
Strategic Planning
Stakeholder Management
Data Collection & Research
Infectious Diseases and Global Health
Pre- and Clinical Research Management
BY-COVID - D3.1 - Metadata standards. Documentation on metadata standards for inclusion of resources in data portal
- Authors: Hermjakob H, Kleemola M, Moilanen K, Tuominen M, Sansone SA, Lister A, David R, Panagiotopoulou M, Ohmann C, Belien J, Lischke J, Juty N, Soiland-Reyes S
- Report: BY-COVID, 2022
- DOI: 10.5281/zenodo.6885015
BY-COVID D3.2: Implementation of cloud-based, high performance, scalable indexing system
- Authors: Hermjakob H, Kleemola M, Moilanen K, Tuominen M, Sansone SA, Lister A, David R, Panagiotopoulou M, Ohmann C, Belien J, Lischke J, Juty N, Soiland-Reyes S
- Report: BY-COVID, 2022
The common message of constraint-based optimization approaches: overflow metabolism is caused by two growth-limiting constraints
- Authors: de Groot DH, Lischke J, Muolo R, Planqué R, Bruggeman FJ, Teusink B
- Journal: Cellular and Molecular Life Sciences 77 (2020)
- DOI: 10.1101/679019
A Distributed Parameter Approach to Model the Transcriptional Response of Escherichia Coli in a Scale-Down Reactor
- Authors: Lischke J, Schmidt K, Von Wulffen J, Sawodny O
- Conference: IEEE CCTA 2018
- DOI: 10.1109/CCTA.2018.8511358
Transition of an Anaerobic Escherichia coli Culture to Aerobiosis: Balancing mRNA and Protein Levels in a Demand-Directed Dynamic Flux Balance Analysis
- Authors: von Wulffen J, RecogNice-Team, Sawodny O, Feuer R, Takors R, Löffler M, Simen J, Ederer M, Lischke J, Kunz S, Rieß O
- Journal: PLoS One, 2016, 11:e0158711
- DOI: 10.1371/journal.pone.0158711
Impairment of energy metabolism in cardiomyocytes caused by 5-FU catabolites can be compensated by administration of amino acids
- Authors: Lischke J, Lang C, Sawodny O, Feuer R
- Conference: IEEE EMBS, 2015
- DOI: 10.1109/EMBC.2015.7319603
Transcriptional response of Escherichia coli to ammonia and glucose fluctuations
- Authors: Simen JD, Löffler M, Jäger G, Feuer R, von Wulffen J, Lischke J, Schäferhoff K, Freund A, Matthes J, Müller J, Takors R
- Journal: Microbial Biotechnology, 2017, 10(4):858-872
- DOI: 10.1111/1751-7915.12713